share_log
Breakings ·  Jul 16 19:06

GlaxoSmithKline: Adults aged 60 to 74 are advised to consider receiving RSV vaccine after consulting with their medical care provider.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment